Novo Nordisk's North American affiliate has a new President and more news from drug delivery firm Enteris - welcome to in-Pharmatechnologist.com' People on the Move.
We begin this week with news from Novo Nordisk who has appointed Jesper Høiland – its former head of International Operations – as President of the company’s North American affiliate.
Høiland, who has been with the company since 1987, said: “This position is a great opportunity to lead an organization that is both driving the growth of our business and helping solve one of the most pressing health challenges facing the United States.”
And read in our sister publication, Biopharma-Reporter.com , about Novo Nordisk’s manufacturing issues holding back approval of its Factor XIII drug.
Copyright - Unless otherwise stated all contents of this web site are © 2016 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
Eli Lilly is conducting several experiments on the International Space Station (ISS) US National Laboratory over the...
The world’s largest modular cGMP biopharmaceutical manufacturing facility came online this week in Wuhan, China.
Valeant, Rentschler, Celgene, MannKind, and Syngene are among those welcoming new leaders for 2016. Oh, and Turing...